Sonuç Sayfası 2 için Sektör: Sağlık Hizmetleri Endüstri: İlaç Üreticileri-Genel Borsası - Teklifler ve Fiyatlar
Fiyatlar, Piyasa Değerleri, PE ve EPS oranları ile tüm Hisse ve Net Varlıkların Listesi
Tüm ülkeler
- {{country.name}}
- Tüm ülkeler
- Amerika Birleşik Devletleri (50)
- Arjantin (13)
- Avustralya (1)
- Avusturya (13)
- Brezilya (14)
- Kanada (2)
- Şili (4)
- Çin (22)
- Finlandiya (2)
- Fransa (3)
- Almanya (58)
- Hong Kong (4)
- Macaristan (1)
- Hindistan (20)
- Endonezya (1)
- İtalya (5)
- Japonya (9)
- Meksika (14)
- Singapur (1)
- Güney Kore (3)
- ispanya (1)
- İsveç (3)
- İsviçre (6)
- Tayvan (1)
- Türkiye (1)
- Birleşik Krallık (20)
Tüm borsalar
- {{item.name}}
- Tüm borsalar
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqGM (1)
- NasdaqGS (7)
- NSE (10)
- NYSE (9)
- Other OTC (33)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
Sağlık Hizmetleri (279)
- {{item.name}}
- Tüm sektörler
- Sağlık Hizmetleri (279)
İlaç Üreticileri-Genel (279)
- {{item.name}}
- Tüm Sektörler
- Biyoteknoloji (2608)
- İlaç Üreticileri-Genel (279)
- İlaç Üreticileri-Özel ve Genel (1702)
- Sağlık Hizmeti Planları (57)
- Tıbbi Bakım Tesisleri (554)
- Farmasötik Perakendeciler (155)
- Sağlık Bilgileri Hizmetleri (420)
- Tıbbi Cihazlar (913)
- Tıbbi Ekipmanlar ve Malzemeler (502)
- Teşhis ve Araştırma (427)
- Medikal Ürün Dağıtımı (138)
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK |
|---|
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. 000908.SZ | $1.96 0.27 USD |
-3.92
|
$1.72B 239.76M USD | $45.79M 6.37M USD | $1.95 0.27 USD | $2.08 0.29 USD | $1.72B 239.76M USD | 0 | -$0.24 -0.03 USD | |
| SMS Pharmaceuticals Limited SMSPHARMA.NS | $205.3 2.48 USD |
+2.01
|
$17.38B 210.26M USD | $143.31K 1.73K USD | $201.15 2.43 USD | $206.95 2.5 USD | $17.38B 210.26M USD | 48.07 | $4.27 0.05 USD | |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd 600671.SS | $8.3 1.15 USD |
+0.24
|
$1.01B 140.54M USD | $781.81K 108.71K USD | $8.15 1.13 USD | $8.43 1.17 USD | $1.01B 140.54M USD | 0 | -$0.32 -0.04 USD | |
| Kopran Limited KOPRAN.NS | $235.75 2.85 USD |
-0.9
|
$11.37B 137.51M USD | $111.86K 1.35K USD | $234.8 2.84 USD | $239.8 2.9 USD | $11.37B 137.51M USD | 28.19 | $8.36 0.1 USD | |
| Yung Zip Chemical Ind. Co., Ltd. 4102.TWO | $35.35 1.12 USD |
-0.14
|
$1.5B 47.6M USD | $61.42K 1.95K USD | $35 1.11 USD | $35.5 1.13 USD | $1.5B 47.6M USD | 20.91 | $1.69 0.05 USD | |
| Modern Chinese Medicine Group Co., Ltd. 1643.HK | $0.3699 0.05 USD |
-6.33
|
$222M 28.39M USD | $93K 11.89K USD | $0.3699 0.05 USD | $0.38 0.05 USD | $222M 28.39M USD | 4.11 | $0.09 0.01 USD | |
| Psyence Group Inc. PSYG.CN | $0.02 0.01 USD |
0
|
$2.75M 2.04M USD | $3 2.23 USD | $0.02 0.01 USD | $0.02 0.01 USD | $2.75M 2.04M USD | 0 | -$0.05 -0.03 USD | |
| Lipidor AB (publ) LIPI.ST | $0.22 0.02 USD |
+6.83
|
$16.06M 1.57M USD | $4.33M 422.49K USD | $0.2 0.02 USD | $0.4199 0.04 USD | $16.06M 1.57M USD | 0 | -$0.4 -0.03 USD | |
| Eli Lilly and Company LILY34.SA | $140.28 28.43 USD |
+0.7
|
$4T 810.67B USD | $17.08K 3.46K USD | $138.74 28.12 USD | $140.56 28.49 USD | $4T 810.67B USD | 120.93 | $1.16 0.24 USD | |
| Eli Lilly and Company LLY.BA | $17,837.5 21.08 USD |
-1.57
|
$683.18T 807.54B USD | $2.59K 3.06 USD | $17,602 20.81 USD | $18,503.5 21.87 USD | $683.18T 807.54B USD | 0.73 | $24.18K 28.58 USD | |
| Eli Lilly and Company LLY.SW | $730 830.58 USD |
0
|
$701.74B 798.43B USD | $15 17.07 USD | $730 830.58 USD | $730 830.58 USD | $701.74B 798.43B USD | 117.55 | $6.21 7.07 USD | |
| Eli Lilly and Company LLYC.VI | $745 814.39 USD |
-0.8
|
$709.73B 775.83B USD | $0 0 USD | $745 814.39 USD | $748.6 818.32 USD | $709.73B 775.83B USD | 119.00 | $6.26 6.84 USD | |
| Eli Lilly and Company LLY.F | $744.2 813.51 USD |
-0.11
|
$709.73B 775.83B USD | $368 402.27 USD | $744.2 813.51 USD | $751.9 821.93 USD | $709.73B 775.83B USD | 119.07 | $6.25 6.83 USD | |
| Eli Lilly and Company LLY.DE | $744.7 814.06 USD |
-0.93
|
$709.73B 775.83B USD | $2.08K 2.27K USD | $742 811.11 USD | $752 822.04 USD | $709.73B 775.83B USD | 118.96 | $6.26 6.84 USD | |
| Eli Lilly and Company LLY.MX | $13,577.55 803.96 USD |
+1.82
|
$12.9T 764.08B USD | $28 1.66 USD | $13,510 799.96 USD | $13,577.55 803.96 USD | $12.9T 764.08B USD | 119.04 | $114.05 6.75 USD | |
| Johnson & Johnson JNJ.BA | $12,077 14.28 USD |
-3.56
|
$314.9T 372.22B USD | $6.73K 7.95 USD | $12,026 14.22 USD | $12,617 14.91 USD | $314.9T 372.22B USD | 10.08 | $1.2K 1.42 USD | |
| Johnson & Johnson JNJB34.SA | $50.87 10.31 USD |
-1.17
|
$1.84T 372.21B USD | $4.47K 906.81 USD | $50.65 10.27 USD | $51.93 10.53 USD | $1.84T 372.21B USD | 22.02 | $2.31 0.47 USD | |
| AstraZeneca PLC AZN.BA | $48,331 57.13 USD |
-1.95
|
$307.87T 363.91B USD | $721 0.85 USD | $47,953 56.68 USD | $49,622.5 58.66 USD | $307.87T 363.91B USD | 910.70 | $53.07 0.06 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$360.28B — | $0 — | $148.27 — | $148.27 — | $360.28B — | 22.03 | $6.73 — | |
| Johnson & Johnson JNJ.VI | $136.84 149.58 USD |
-1.88
|
$329.33B 360B USD | $73 79.8 USD | $136.84 149.58 USD | $138.44 151.33 USD | $329.33B 360B USD | 22.03 | $6.21 6.79 USD | |
| Johnson & Johnson JNJ.DE | $136.72 149.45 USD |
-1.89
|
$329.04B 359.69B USD | $2.37K 2.59K USD | $136.56 149.28 USD | $138.8 151.73 USD | $329.04B 359.69B USD | 21.98 | $6.22 6.8 USD | |
| Johnson & Johnson JNJ.F | $135.52 148.14 USD |
-2.43
|
$327.14B 357.6B USD | $746 815.48 USD | $135.52 148.14 USD | $138.96 151.9 USD | $327.14B 357.6B USD | 21.78 | $6.22 6.8 USD | |
| Johnson & Johnson JNJ.MX | $2,475.35 146.57 USD |
-1.54
|
$5.96T 352.75B USD | $1.02K 60.22 USD | $2,453 145.25 USD | $2,513.99 148.86 USD | $5.96T 352.75B USD | 21.97 | $112.63 6.67 USD | |
| Merck & Co., Inc. MRK.BA | $32,045 37.88 USD |
-2.55
|
$291.98T 345.14B USD | $200 0.24 USD | $31,576 37.32 USD | $33,166 39.2 USD | $291.98T 345.14B USD | 4.00 | $8.01K 9.47 USD | |
| Merck & Co., Inc. MRCK34.SA | $83.82 16.99 USD |
-0.83
|
$1.7T 344.24B USD | $4.3K 871.74 USD | $83.2 16.86 USD | $84.08 17.04 USD | $1.7T 344.24B USD | 144.51 | $0.58 0.12 USD | |
| Merck & Co., Inc. 6MK.F | $121 132.27 USD |
0
|
$306.47B 335.01B USD | $65 71.05 USD | $121 132.27 USD | $121.2 132.49 USD | $306.47B 335.01B USD | 145.78 | $0.83 0.91 USD | |
| Merck & Co., Inc. MRK.SN | $127.62 — |
+1.82
|
$333.94B — | $0 — | $127.62 — | $127.62 — | $333.94B — | 141.80 | $0.9 — | |
| Merck & Co., Inc. 6MK.DE | $120 131.18 USD |
-0.99
|
$303.94B 332.24B USD | $133 145.39 USD | $120 131.18 USD | $121.8 133.14 USD | $303.94B 332.24B USD | 144.57 | $0.83 0.91 USD | |
| Merck & Co., Inc. MRK.VI | $120 131.18 USD |
-0.99
|
$303.94B 332.24B USD | $0 0 USD | $120 131.18 USD | $121.2 132.49 USD | $303.94B 332.24B USD | 144.57 | $0.83 0.91 USD | |
| Merck & Co., Inc. MRK.MX | $2,180 129.08 USD |
-0.23
|
$5.52T 326.94B USD | $18 1.07 USD | $2,180 129.08 USD | $2,185 129.38 USD | $5.52T 326.94B USD | 144.94 | $15.04 0.89 USD | |
| AbbVie Inc. ABBV34.SA | $50.45 10.23 USD |
-1.83
|
$1.43T 289.28B USD | $115 23.31 USD | $50.45 10.23 USD | $53 10.74 USD | $1.43T 289.28B USD | 46.71 | $1.08 0.22 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| AbbVie Inc. 4AB.DE | $145.16 158.68 USD |
-1.53
|
$256.51B 280.4B USD | $609 665.72 USD | $145.16 158.68 USD | $146.7 160.36 USD | $256.51B 280.4B USD | 46.67 | $3.11 3.4 USD | |
| AbbVie Inc. ABBV.VI | $145.14 158.66 USD |
-1.44
|
$256.51B 280.4B USD | $0 0 USD | $145.14 158.66 USD | $146.28 159.9 USD | $256.51B 280.4B USD | 46.66 | $3.11 3.4 USD | |
| AbbVie Inc. 4AB.F | $144.98 158.48 USD |
-1.71
|
$256.51B 280.4B USD | $123 134.46 USD | $144.98 158.48 USD | $146.7 160.36 USD | $256.51B 280.4B USD | 46.76 | $3.1 3.39 USD | |
| AbbVie Inc. ABBV.MX | $2,630 155.73 USD |
-4.68
|
$4.64T 275B USD | $28 1.66 USD | $2,630 155.73 USD | $2,637 156.14 USD | $4.64T 275B USD | 46.73 | $56.28 3.33 USD | |
| AstraZeneca PLC A1ZN34.SA | $67.7 13.72 USD |
+0.53
|
$1.26T 255.51B USD | $3.9K 790.87 USD | $65.99 13.38 USD | $67.83 13.75 USD | $1.26T 255.51B USD | 19.51 | $3.47 0.7 USD | |
| AstraZeneca PLC AZNCF | $159.12 — |
-0.15
|
$246.67B — | $2.75K — | $153.61 — | $159.12 — | $246.67B — | 39.19 | $4.06 — | |
| AstraZeneca PLC ZEGA.F | $72 78.71 USD |
-2.04
|
$223.78B 244.62B USD | $79 86.36 USD | $72 78.71 USD | $72 78.71 USD | $223.78B 244.62B USD | 38.50 | $1.87 2.04 USD | |
| AstraZeneca PLC ZEG.F | $144.3 157.74 USD |
-1.13
|
$223.78B 244.62B USD | $300 327.94 USD | $143.95 157.36 USD | $145.05 158.56 USD | $223.78B 244.62B USD | 38.47 | $3.75 4.1 USD | |
| AstraZeneca PLC AZNN.MX | $1,303.5 77.18 USD |
0
|
$4.05T 239.76B USD | $1 0.06 USD | $1,303.5 77.18 USD | $1,303.5 77.18 USD | $4.05T 239.76B USD | 38.46 | $33.89 2.01 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Novartis AG NVS.BA | $31,040 36.69 USD |
-2.49
|
$182.24T 215.41B USD | $26 0.03 USD | $31,002.5 36.65 USD | $31,466.5 37.19 USD | $182.24T 215.41B USD | 3.96 | $7.83K 9.26 USD | |
| Novartis AG N1VS34.SA | $52.25 10.59 USD |
+0.33
|
$1.05T 213.51B USD | $2 0.41 USD | $51.8 10.5 USD | $52.25 10.59 USD | $1.05T 213.51B USD | 2.30 | $22.65 4.59 USD | |
| Novartis AG NOTA.F | $92.4 101.01 USD |
-0.22
|
$189.32B 206.95B USD | $5 5.47 USD | $92.4 101.01 USD | $92.4 101.01 USD | $189.32B 206.95B USD | 22.70 | $4.07 4.45 USD | |
| Roche Holding AG RHO6.F | $28.91 31.6 USD |
+0.02
|
$188.11B 205.63B USD | $60 65.59 USD | $28.91 31.6 USD | $28.91 31.6 USD | $188.11B 205.63B USD | 15.96 | $1.81 1.98 USD | |
| Novartis AG NVSN.MX | $1,655.6 98.03 USD |
0
|
$3.45T 204.06B USD | $0 0 USD | $1,655.6 98.03 USD | $1,655.6 98.03 USD | $3.45T 204.06B USD | 22.47 | $73.67 4.36 USD | |
| Roche Holding AG RHHBF | $270.06 — |
-4.23
|
$203.39B — | $11 — | $270.06 — | $281 — | $203.39B — | 17.26 | $15.64 — | |
| Roche Holding AG ROGN.MX | $4,484.92 265.56 USD |
0
|
$3.4T 201.54B USD | $5 0.3 USD | $4,484.92 265.56 USD | $4,484.92 265.56 USD | $3.4T 201.54B USD | 17.12 | $261.92 15.51 USD | |
| Amgen Inc. AMGN34.SA | $56.88 11.53 USD |
+0.21
|
$854.35B 173.16B USD | $1 0.2 USD | $56.88 11.53 USD | $56.88 11.53 USD | $854.35B 173.16B USD | 44.09 | $1.29 0.26 USD | |
| Amgen Inc. AMGN.BA | $12,548.5 14.83 USD |
-1.94
|
$146.06T 172.65B USD | $1.8K 2.13 USD | $12,433.5 14.7 USD | $12,999.5 15.37 USD | $146.06T 172.65B USD | 0.40 | $31.16K 36.83 USD | |
| Pfizer Inc. PFE.BA | $8,903 10.52 USD |
-1.24
|
$145.69T 172.22B USD | $41.97K 49.61 USD | $8,688.5 10.27 USD | $9,254 10.94 USD | $145.69T 172.22B USD | 0 | -$89.03 -0.1 USD | |
| Pfizer Inc. PFE.VI | $27.34 29.89 USD |
+2.8
|
$154.92B 169.35B USD | $115 125.71 USD | $26.56 29.03 USD | $27.34 29.89 USD | $154.92B 169.35B USD | 0 | -$0.05 -0.05 USD | |
| Amgen Inc. AMG.DE | $282.75 309.08 USD |
-0.98
|
$151.74B 165.87B USD | $547 597.94 USD | $281.4 307.61 USD | $284.45 310.94 USD | $151.74B 165.87B USD | 43.70 | $6.47 7.07 USD | |
| Amgen Inc. AMG.F | $281.8 308.05 USD |
-1.59
|
$151.74B 165.87B USD | $235 256.89 USD | $281.8 308.05 USD | $283 309.36 USD | $151.74B 165.87B USD | 43.48 | $6.48 7.08 USD | |
| Amgen Inc. AMGN.VI | $282.6 308.92 USD |
-0.93
|
$151.74B 165.87B USD | $106 115.87 USD | $281.25 307.44 USD | $283.65 310.07 USD | $151.74B 165.87B USD | 43.67 | $6.47 7.07 USD | |
| Pfizer Inc. PFEB.F | $8.9 9.73 USD |
-3.26
|
$151.36B 165.45B USD | $21 22.96 USD | $8.9 9.73 USD | $8.9 9.73 USD | $151.36B 165.45B USD | 0 | -$0.05 -0.05 USD | |
| Amgen Inc. AMGN.MX | $5,185 307.02 USD |
0
|
$2.78T 164.69B USD | $0 0 USD | $5,185 307.02 USD | $5,185 307.02 USD | $2.78T 164.69B USD | 44.24 | $117.18 6.94 USD | |
| Pfizer Inc. PFE.SN | $28.9 — |
0
|
$163.76B — | $0 — | $28.9 — | $28.9 — | $163.76B — | 0 | -$0.05 — | |
| Pfizer Inc. PFE.MX | $480.8 28.47 USD |
-0.12
|
$2.74T 162.17B USD | $1.4K 82.96 USD | $476.79 28.23 USD | $480.8 28.47 USD | $2.74T 162.17B USD | 0 | -$0.82 -0.04 USD | |
| GSK plc GSK.BA | $13,904 16.43 USD |
-2.06
|
$113.4T 134.04B USD | $62 0.07 USD | $13,868 16.39 USD | $14,200.5 16.79 USD | $113.4T 134.04B USD | 22.62 | $614.56 0.73 USD | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Sanofi 0A2V.IL | $48.7 — |
-0.45
|
$129.23B — | $40.6K — | $48.52 — | $48.8 — | $129.23B — | 13.52 | $3.6 — | |
| Sanofi SANO.VI | $90.3 98.71 USD |
-0.09
|
$112.85B 123.36B USD | $0 0 USD | $90.3 98.71 USD | $90.3 98.71 USD | $112.85B 123.36B USD | 25.01 | $3.61 3.95 USD | |
| Sanofi SNW.F | $89.65 98 USD |
-1.8
|
$112.04B 122.47B USD | $153 167.25 USD | $89.65 98 USD | $90.67 99.11 USD | $112.04B 122.47B USD | 24.83 | $3.61 3.95 USD | |
| Sanofi SNW.DE | $89.3 97.62 USD |
-0.78
|
$111.87B 122.29B USD | $2K 2.19K USD | $89.3 97.62 USD | $90.32 98.73 USD | $111.87B 122.29B USD | 24.73 | $3.61 3.95 USD | |
| Sanofi SNW2.F | $44.6 48.75 USD |
-1.76
|
$111.87B 122.29B USD | $240 262.35 USD | $44.6 48.75 USD | $44.6 48.75 USD | $111.87B 122.29B USD | 24.64 | $1.81 1.98 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc G1SK34.SA | $45.75 9.27 USD |
0
|
$480.45B 97.38B USD | $0 0 USD | $45.75 9.27 USD | $45.75 9.27 USD | $480.45B 97.38B USD | 6.44 | $7.1 1.44 USD | |
| GSK GLAXF | $22.96 — |
+0.92
|
$93.74B — | $1.06K — | $22.96 — | $22.96 — | $93.74B — | 16.63 | $1.38 — | |
| GSK plc GSKN.MX | $745 44.11 USD |
0
|
$1.56T 92.51B USD | $152 9 USD | $745 44.11 USD | $745 44.11 USD | $1.56T 92.51B USD | 16.12 | $46.19 2.74 USD | |
| Bristol-Myers Squibb Company BMY.BA | $16,927 20.01 USD |
-2.67
|
$74.42T 87.97B USD | $1.16K 1.38 USD | $16,850 19.92 USD | $17,587 20.79 USD | $74.42T 87.97B USD | 0 | -$2,759 -3.2 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $213.69 43.31 USD |
-0.39
|
$433.17B 87.8B USD | $10 2.03 USD | $212.84 43.14 USD | $214 43.37 USD | $433.17B 87.8B USD | 0 | -$15.96 -3.2 USD | |
| Gilead Sciences, Inc. GILD.BA | $20,203.5 23.88 USD |
-2.68
|
$72.85T 86.11B USD | $948 1.12 USD | $19,880.5 23.5 USD | $20,950 24.76 USD | $72.85T 86.11B USD | 62.89 | $321.24 0.38 USD | |
| Gilead Sciences, Inc. GILD34.SA | $169.93 34.44 USD |
0
|
$423.42B 85.82B USD | $0 0 USD | $169.93 34.44 USD | $169.93 34.44 USD | $423.42B 85.82B USD | 182.72 | $0.93 0.19 USD | |
| Bristol-Myers Squibb Company BRM.F | $37.95 41.48 USD |
-0.97
|
$77.32B 84.52B USD | $4.81K 5.26K USD | $37.95 41.48 USD | $39.2 42.85 USD | $77.32B 84.52B USD | 0 | -$2.87 -3.1 USD | |
| Bristol-Myers Squibb Company BRM.DE | $38.14 41.69 USD |
-1.36
|
$77.32B 84.52B USD | $18.42K 20.14K USD | $37.95 41.48 USD | $38.96 42.58 USD | $77.32B 84.52B USD | 0 | -$2.87 -3.1 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $38.14 41.69 USD |
-1.22
|
$77.32B 84.52B USD | $50 54.66 USD | $38.11 41.65 USD | $38.52 42.11 USD | $77.32B 84.52B USD | 0 | -$2.86 -3.1 USD | |
| Gilead Sciences, Inc. GILD.MX | $1,129 66.85 USD |
0
|
$1.41T 83.29B USD | $20 1.18 USD | $1,129 66.85 USD | $1,129 66.85 USD | $1.41T 83.29B USD | 188.79 | $5.98 0.35 USD | |
| Bristol-Myers Squibb Company BMY.MX | $690.5 40.89 USD |
-0.6
|
$1.4T 82.88B USD | $168 9.95 USD | $690.5 40.89 USD | $690.5 40.89 USD | $1.4T 82.88B USD | 0 | -$51.85 -3.07 USD | |
| Gilead Sciences, Inc. GILD.VI | $60.46 66.09 USD |
-2.04
|
$75.68B 82.73B USD | $0 0 USD | $60.46 66.09 USD | $61.17 66.87 USD | $75.68B 82.73B USD | 183.21 | $0.33 0.36 USD | |
| Gilead Sciences, Inc. GIS.DE | $60.48 66.11 USD |
-2.04
|
$75.68B 82.73B USD | $1.58K 1.72K USD | $60.36 65.98 USD | $61.52 67.25 USD | $75.68B 82.73B USD | 183.27 | $0.33 0.36 USD | |
| Gilead Sciences, Inc. GIS.F | $60.45 66.08 USD |
-1.23
|
$75.68B 82.73B USD | $640 699.61 USD | $60.45 66.08 USD | $61.24 66.94 USD | $75.68B 82.73B USD | 183.18 | $0.33 0.36 USD | |
| Gilead Sciences, Inc. GILD.SN | $57.39 — |
-12.45
|
$71.5B — | $0 — | $57.39 — | $57.39 — | $71.5B — | 17.55 | $3.27 — | |
| Daiichi Sankyo Company, Limited D4S.F | $31.62 34.56 USD |
+0.96
|
$61.5B 67.22B USD | $191 208.79 USD | $31.62 34.56 USD | $31.62 34.56 USD | $61.5B 67.22B USD | 51.00 | $0.62 0.68 USD | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $27.25 29.79 USD |
-0.98
|
$46.02B 50.31B USD | $54 59.03 USD | $27.25 29.79 USD | $27.35 29.9 USD | $46.02B 50.31B USD | 23.29 | $1.17 1.28 USD | |
| Chugai Pharmaceutical CHGCF | $29.75 — |
-8.26
|
$49.76B — | $3.33K — | $29.75 — | $29.75 — | $49.76B — | 23.61 | $1.26 — | |
| Biogen Inc. BIIB.BA | $20,698.5 24.47 USD |
-2
|
$28.23T 33.37B USD | $299 0.35 USD | $20,469 24.2 USD | $20,900 24.7 USD | $28.23T 33.37B USD | 2.90 | $7.12K 8.42 USD | |
| Biogen Inc. BIIB34.SA | $171.36 34.73 USD |
0
|
$163.64B 33.17B USD | $0 0 USD | $171.36 34.73 USD | $171.36 34.73 USD | $163.64B 33.17B USD | 25.05 | $6.84 1.39 USD | |
| Biogen Inc. BIIB.MX | $3,836 227.14 USD |
0
|
$558.51B 33.07B USD | $5 0.3 USD | $3,836 227.14 USD | $3,836 227.14 USD | $558.51B 33.07B USD | 28.65 | $133.88 7.93 USD | |
| Biogen Inc. IDP.DE | $201.7 220.49 USD |
-0.69
|
$29.37B 32.1B USD | $510 557.5 USD | $201.6 220.38 USD | $208.9 228.36 USD | $29.37B 32.1B USD | 27.25 | $7.4 8.09 USD | |
| Biogen Inc. BIIB.VI | $201.4 220.16 USD |
-0.59
|
$29.33B 32.06B USD | $40 43.73 USD | $201.4 220.16 USD | $204 223 USD | $29.33B 32.06B USD | 27.25 | $7.39 8.08 USD | |
| Biogen Inc. IDP.F | $200.8 219.5 USD |
-0.5
|
$29.33B 32.06B USD | $15 16.4 USD | $200.8 219.5 USD | $200.8 219.5 USD | $29.33B 32.06B USD | 27.17 | $7.39 8.08 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $27.72 30.3 USD |
-0.29
|
$27.23B 29.76B USD | $232 253.61 USD | $27.34 29.89 USD | $27.72 30.3 USD | $27.23B 29.76B USD | 0 | -$3.17 -3.4 USD | |
| Bayer Aktiengesellschaft BAYA.F | $6.75 7.38 USD |
-0.74
|
$27.14B 29.67B USD | $624 682.12 USD | $6.55 7.16 USD | $6.75 7.38 USD | $27.14B 29.67B USD | 0 | -$0.79 -0.8 USD | |
| Bayer Aktiengesellschaft BAYER.BD | $10,578 29.26 USD |
-2.02
|
$10.49T 29.02B USD | $236 0.65 USD | $10,510 29.07 USD | $10,602 29.32 USD | $10.49T 29.02B USD | 0 | -$1,228 -3.3 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $36.2 39.57 USD |
+0.56
|
$19.76B 21.61B USD | $5 5.47 USD | $36 39.35 USD | $36.2 39.57 USD | $19.76B 21.61B USD | 24.13 | $1.5 1.64 USD | |
| Astellas Pharma Inc. YPHA.F | $8.75 9.56 USD |
+1.16
|
$16.54B 18.08B USD | $500 546.57 USD | $8.75 9.56 USD | $8.75 9.56 USD | $16.54B 18.08B USD | 145.83 | $0.06 0.07 USD | |
| Astellas Pharma Inc. YPH.F | $8.94 9.77 USD |
+0.45
|
$16.54B 18.08B USD | $1.5K 1.64K USD | $8.91 9.74 USD | $9.2 10.06 USD | $16.54B 18.08B USD | 149.03 | $0.06 0.07 USD | |
|
Favori hisse senedi yok.
Henüz favori bir hisse senediniz yok, lütfen burada görmek için favorilere ekleyin |
||||||||||
- {{ link.label }} {{link}}